13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 124 holding rows worth $2,449,410,000.
- Accession
- 0001140361-14-021676
- Filer
- CIK 1009258
- Filed
- 2014-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2014
A holdings report, 124 entries on the cover page, a total value of $2,449,410,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,449,414,000 with VALUE read as thousands by filing date, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HUMANA INC COM | 444859102 | Stock | 1,280,000 | $144,282,000 | thousands by filing date | call |
| DENDREON CORP | 24823QAC1 | CORPORATE OBLIG | 183,660,000 | $133,789,000 | thousands by filing date | principal |
| FLAMEL TECHNOLOGIES-SP ADR | 338488109 | SPON | 5,258,475 | $70,464,000 | thousands by filing date | |
| AUXILIUM PHARMACEUTICALS | 05334D107 | COMMON STOCK | 2,566,705 | $69,763,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 709,689 | $69,699,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,428,569 | $68,607,000 | thousands by filing date | |
| QUESTCOR PHARMACEUTICALS INC | 74835Y101 | COM | 1,039,865 | $67,518,000 | thousands by filing date | |
| AUSPEX PHARMACE | 05211J102 | Common Stock | 1,988,990 | $61,181,000 | thousands by filing date | |
| VOLCANO CORP | 928645AB6 | CORPORATE OBLIG | 60,500,000 | $59,767,000 | thousands by filing date | principal |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 12,205,673 | $57,367,000 | thousands by filing date | |
| INTERMUNE INC | 45884X103 | COM | 1,583,942 | $53,015,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 4,444,027 | $52,839,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 1,025,000 | $52,685,000 | thousands by filing date | |
| INTERMUNE INC | 45884XAE3 | NOTE 2.500% 9/1 | 40,295,000 | $51,373,000 | thousands by filing date | principal |
| QUESTCOR PHARMACEUTICALS INC | 74835Y101 | COM | 750,000 | $48,698,000 | thousands by filing date | call |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 3,801,175 | $48,427,000 | thousands by filing date | |
| INTEGRA LIFESCIENCES HLD | 457985AK5 | NOTE | 41,523,000 | $43,698,000 | thousands by filing date | principal |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 2,016,147 | $38,387,000 | thousands by filing date | |
| HOLOGIC INC | 436440AC5 | CORPORATE OBLIG | 37,516,000 | $38,347,000 | thousands by filing date | principal |
| AMAG PHARMACEUTICALS INC | 00163UAA4 | NOTE 2.500 2/1 | 34,520,000 | $34,986,000 | thousands by filing date | principal |
| DYAX CORP | 26746E103 | COM | 3,786,478 | $34,003,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 3,986,760 | $33,648,000 | thousands by filing date | |
| INTERMUNE INC | 45884X103 | COM | 1,000,000 | $33,470,000 | thousands by filing date | call |
| ANTARES PHARMA INC | 036642106 | COM | 9,488,461 | $33,210,000 | thousands by filing date | |
| TORNIER NV | N87237108 | COMMON STOCK-FO | 1,554,075 | $32,977,000 | thousands by filing date | |
| UNIVERSAL AMERN CORP NEW | 91338E101 | COM | 4,600,993 | $32,529,000 | thousands by filing date | |
| ACCURAY INC | 004397AB1 | CNV | 25,700,000 | $30,767,000 | thousands by filing date | principal |
| AIR METHODS CORP | 009128307 | COM PAR $.06 | 552,544 | $29,522,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 5,406,110 | $28,923,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 163,000 | $28,781,000 | thousands by filing date | |
| MEDTRONIC INC | 585055106 | COM | 464,000 | $28,555,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 477,200 | $27,091,000 | thousands by filing date | |
| ALLERGAN INC | 018490102 | COM | 215,636 | $26,760,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 26,000,000 | $26,665,000 | thousands by filing date | principal |
| SYNAGEVA BIOPHARMA CORP | 87159A103 | COM | 317,678 | $26,358,000 | thousands by filing date | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 440,303 | $25,502,000 | thousands by filing date | |
| DAVITA INC COM | 23918K108 | Stock | 348,011 | $23,961,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 1,403,105 | $23,909,000 | thousands by filing date | |
| XENOPORT INC | 98411C100 | COM | 4,384,797 | $22,669,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 302,000 | $20,276,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 769,848 | $19,939,000 | thousands by filing date | |
| HORIZON PHARMA INC | 44047T109 | COM | 1,310,930 | $19,821,000 | thousands by filing date | |
| INTERMUNE INC | 45884XAF0 | NOTE 2.500%12/1 | 7,500,000 | $19,618,000 | thousands by filing date | principal |
| ATRIUM THERAPEUTICS INC | N71546100 | COM | 3,211,372 | $18,080,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 591,431 | $17,832,000 | thousands by filing date | |
| ZOGENIX INC | 98978L105 | COM | 6,174,809 | $17,567,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 451,391 | $16,954,000 | thousands by filing date | |
| OVASCIENCE INC | 69014Q101 | COM | 1,672,549 | $14,953,000 | thousands by filing date | |
| ARATANA THERAPEUTICS INC | 03874P101 | COM | 788,904 | $14,642,000 | thousands by filing date | |
| ZOETIS INC CL A | 98978V103 | Stock | 500,000 | $14,470,000 | thousands by filing date | call |
| DENDREON CORP | 24823QAB3 | NOTE 4.750% 6/1 | 14,740,000 | $14,308,000 | thousands by filing date | principal |
| EHEALTH INC | 28238P109 | COM | 271,000 | $13,767,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 1,164,575 | $12,962,000 | thousands by filing date | |
| ALLERGAN INC | 018490102 | COM | 100,000 | $12,410,000 | thousands by filing date | call |
| GENOCEA BIOSCIENCES INC | 372427104 | COM | 659,983 | $12,005,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 565,180 | $11,976,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266SAA4 | NOTE 2.250%12/1 | 12,450,000 | $11,930,000 | thousands by filing date | principal |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 371,572 | $11,649,000 | thousands by filing date | |
| Foundation Medicine Inc | 350465100 | COM | 342,921 | $11,100,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 2,628,972 | $11,068,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 534,930 | $10,351,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 1,311,290 | $10,346,000 | thousands by filing date | |
| SPECTRUM PHARMACEUTICALS INC | 84763A108 | COM | 1,265,375 | $9,921,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 907,920 | $9,606,000 | thousands by filing date | |
| ARAY 3.5 02/18 | 004397AD7 | Bond 30/360P2 U | 5,000,000 | $9,546,000 | thousands by filing date | principal |
| ZELTIQ AESTHETICS INC | 98933Q108 | COM | 483,520 | $9,482,000 | thousands by filing date | |
| INTEGRA LIFESCIENCES HLDGS C | 457985208 | COM NEW | 206,128 | $9,480,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 414,474 | $9,425,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 683,458 | $8,796,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 617,649 | $8,307,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 317,530 | $8,300,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 501,709 | $8,153,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 391,105 | $8,076,000 | thousands by filing date | |
| CAPITAL SENIOR LIVING CORP | 140475104 | COM | 308,088 | $8,007,000 | thousands by filing date | |
| DISCOVERY LABORATORIES INC N | 254668403 | COM NEW | 3,659,700 | $7,868,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 124,795 | $7,768,000 | thousands by filing date | |
| ARENA PHARMECEUTICALS INC | 040047102 | COMMON STOCK | 1,216,579 | $7,664,000 | thousands by filing date | |
| KALOBIOS PHARMACEUTICALS INC | 48344T100 | COM | 2,786,783 | $7,552,000 | thousands by filing date | |
| SQNM 5 10/1/17 | 817337AB4 | Bond 30/360P2 U | 8,377,000 | $7,466,000 | thousands by filing date | principal |
| CAS MED SYS INC | 124769209 | COM | 3,200,000 | $6,944,000 | thousands by filing date | |
| AUXILIUM PHARMACEUTICALS | 05334D107 | COMMON STOCK | 250,000 | $6,795,000 | thousands by filing date | put |
| AMEDISYS INC | 023436108 | COM | 439,000 | $6,537,000 | thousands by filing date | |
| ALERE INC | 01449JAA3 | CORPORATE OBLIG | 5,750,000 | $6,278,000 | thousands by filing date | principal |
| BAXTER INTL INC | 071813109 | COM | 85,000 | $6,254,000 | thousands by filing date | |
| ALPHATEC HOLDINGS INC | 02081G102 | COM | 3,982,738 | $5,974,000 | thousands by filing date | |
| INOGEN INC | 45780L104 | COM | 357,269 | $5,899,000 | thousands by filing date | |
| STREAMLINE HEALTH SOLUTIONS | 86323X106 | COM | 1,140,100 | $5,735,000 | thousands by filing date | |
| ANTHERA PHARMACEUTCLS INC | 03674U201 | Common equity shares | 1,691,857 | $5,668,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 78,500 | $5,552,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 350,000 | $5,453,000 | thousands by filing date | |
| XOMA CORP DEL | 98419J107 | COM | 1,000,000 | $5,210,000 | thousands by filing date | call |
| CANCER GENETICS INC. | 13739u104 | COM | 318,012 | $4,799,000 | thousands by filing date | |
| LIPOSCIENCE INC | 53630M108 | COM | 1,382,350 | $4,410,000 | thousands by filing date | |
| NANOSPHERE INC | 63009F105 | COM | 2,000,000 | $4,300,000 | thousands by filing date | |
| MANNKIND CORP | 56400P201 | COM | 1,000,000 | $4,020,000 | thousands by filing date | put |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,027,443 | $3,986,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 300,000 | $3,804,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 116,689 | $3,676,000 | thousands by filing date | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 284,653 | $3,629,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 11,750 | $3,594,000 | thousands by filing date | |
| AUXILIUM PHARMACEUTICALS INC | 05334DAA5 | NOTE 1.500% 7/1 | 2,500,000 | $3,278,000 | thousands by filing date | principal |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 171,437 | $3,117,000 | thousands by filing date | |
| OXYGEN BIOTHERAPEUTICS INC | 69207P308 | COM PAR $0.0001 | 550,000 | $3,053,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328601 | COM NEW | 455,741 | $3,012,000 | thousands by filing date | |
| TARGACEPT INC | 87611R306 | COM | 617,000 | $2,931,000 | thousands by filing date | |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 261,119 | $2,755,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 17,697 | $2,631,000 | thousands by filing date | |
| TONIX PHARMACEUTICALS HOLDING | 890260201 | COM NEW | 244,524 | $2,545,000 | thousands by filing date | |
| PALATIN TECHNOLOGIES INC | 696077403 | COM PAR $ .01 | 2,000,000 | $2,460,000 | thousands by filing date | |
| THERAPEUTICSMD INC | 88338N107 | COM | 376,049 | $2,373,000 | thousands by filing date | |
| MERGE HEALTHCARE INC | 589499102 | COM | 959,580 | $2,341,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 500,000 | $1,770,000 | thousands by filing date | call |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 4,799 | $1,441,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 400,000 | $1,416,000 | thousands by filing date | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 25,000 | $1,398,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 77,994 | $1,256,000 | thousands by filing date | |
| FURIEX PHARMACEUTICALS | 36106P101 | COM | 13,340 | $1,161,000 | thousands by filing date | |
| HOLOGIC INC | 436440101 | COM | 42,500 | $914,000 | thousands by filing date | |
| MYLAN INC | 628530107 | COM | 17,500 | $855,000 | thousands by filing date | |
| MEDIVATION INC | 58501N101 | COM | 12,500 | $805,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 62,387 | $794,000 | thousands by filing date | |
| SYNERON MEDICAL LTD | M87245102 | ORD | 34,518 | $430,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 92,804 | $305,000 | thousands by filing date | |
| NOVADAQ TECHNOLOGIES INC COMMON | 66987G102 | COM | 10,000 | $223,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-14-021676 | this filing | 2014-05-15 | acceptance time not in the bulk data set |